Pharmacy Students' Ability to Identify Potential Drug-Drug Interactions

被引:11
|
作者
Saverno, Kim R. [1 ]
Malone, Daniel C. [1 ]
Kurowsky, John [1 ]
机构
[1] Univ Arizona, Coll Pharm, Tucson, AZ 85721 USA
关键词
drug interaction; ALERTS; RECOGNITION; KNOWLEDGE; RISK;
D O I
10.5688/aj730227
中图分类号
G40 [教育学];
学科分类号
040101 ; 120403 ;
摘要
Objective. To evaluate the ability of third- and fourth-year pharmacy students to identify clinically significant drug-drug interactions (DDIs) Methods. A questionnaire designed to measure DDI knowledge was disseminated to fourth-year pharmacy students in a school of pharmacy. A second questionnaire was distributed to third- year pharmacy students in 2 schools of pharmacy (schools A and B) and re-administered to students in 1 of the schools 1 year later. Results. Class of 2005 fourth-year pharmacy students correctly categorized an average of 52% +/- 13% DDI pairs on the first questionnaire. Third-year pharmacy students at schools A and B correctly categorized an average of 61% +/- 18% and 66% +/- 15% of DDI pairs, respectively. The average percentage of correct responses for fourth-year students from the class of 2007 was 65% (+/- 17%). Conclusion. Pharmacy students' ability to identify important DDIs is far from optimal, even after completing experiential requirements.
引用
收藏
页数:8
相关论文
共 50 条
  • [42] Clozapine drug-drug interactions: A review of the literature
    Edge, SC
    Markowitz, JS
    Devane, CL
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 1997, 12 (01) : 5 - 20
  • [43] Drug-drug interactions you should know!
    Voigt, Niels
    Ort, Katharina
    Sossalla, Samuel
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2019, 144 (04) : 264 - 275
  • [44] Magnitude of Drug-Drug Interactions in Special Populations
    Bettonte, Sara
    Berton, Mattia
    Marzolini, Catia
    PHARMACEUTICS, 2022, 14 (04)
  • [45] Potential drug-drug interactions among pneumonia patients: do these matter in clinical perspectives?
    Noor, Sidra
    Ismail, Mohammad
    Ali, Zahid
    BMC PHARMACOLOGY & TOXICOLOGY, 2019, 20 (1)
  • [46] Evaluation of Potential Drug-Drug Interactions With Direct Oral Anticoagulants in a Large Urban Hospital
    Mo, Yoonsun
    Karakas-Torgut, Ayse
    Pham, Antony Q.
    JOURNAL OF PHARMACY PRACTICE, 2020, 33 (02) : 136 - 141
  • [47] Assessment of Physician's Knowledge of Potential Drug-Drug Interactions: An Online Survey in China
    Yuan, Jing
    Shen, Chunying
    Wang, Chengnan
    Shen, Gang
    Han, Bing
    FRONTIERS IN MEDICINE, 2021, 8
  • [48] Prevalence of Potential Drug-Drug Interactions Involving Antiretroviral Drugs in a Large Kenyan Cohort
    Kigen, Gabriel
    Kimaiyo, Sylvester
    Nyandiko, Winstone
    Faragher, Brian
    Sang, Edwin
    Jakait, Beatrice
    Owen, Andrew
    Back, David
    Gibbons, Sara
    Seden, Kay
    Khoo, Saye H.
    PLOS ONE, 2011, 6 (02):
  • [49] Prevalence of comedications and effect of potential drug-drug interactions in the Swiss HIV Cohort Study
    Marzolini, Catia
    Elzi, Luigia
    Gibbons, Sara
    Weber, Rainer
    Fux, Christoph
    Furrer, Hansjakob
    Chave, Jean-Philippe
    Cavassini, Matthias
    Bernasconi, Enos
    Calmy, Alexandra
    Vernazza, Pietro
    Khoo, Saye
    Ledergerber, Bruno
    Back, David
    Battegay, Manuel
    ANTIVIRAL THERAPY, 2010, 15 (03) : 413 - 423
  • [50] Potential drug-drug interactions of OMBITASVIR, PARITAPREVIR/ritonavir ± DASABUVIR ± ribavirin in clinical practice
    Gonzalez-Colominas, Elena
    Londono, Maria-Carlota
    Morillas, Rosa M.
    Torras, Xavier
    Mojal, Sergi
    Lens, Sabela
    Lopez, Dulce
    Gallego, Adolfo
    Marino, Zoe
    Ardevol, Merce
    Pages, Neus
    Sola, Ricard
    Carrion, Jose A.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 (05) : 1100 - 1107